1292 related articles for article (PubMed ID: 16120030)
21. Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A randomized open-labelled parallel study.
Ruiz-de-Adana MS; Dominguez-Lopez ME; Gonzalez-Molero I; Machado A; Martin V; Cardona I; de-la-Higuera M; Tapia MJ; Soriguer F; Anarte MT; Rojo-Martínez G
Med Clin (Barc); 2016 Mar; 146(6):239-46. PubMed ID: 26656958
[TBL] [Abstract][Full Text] [Related]
22. Does the timing of insulin pump therapy initiation after type 1 diabetes onset have an impact on glycemic control?
Shalitin S; Lahav-Ritte T; Lebenthal Y; Devries L; Phillip M
Diabetes Technol Ther; 2012 May; 14(5):389-97. PubMed ID: 22283639
[TBL] [Abstract][Full Text] [Related]
23. Does treatment with an insulin pump improve glycaemic control in children and adolescents with type 1 diabetes? A retrospective case-control study.
Brorsson AL; Viklund G; Örtqvist E; Lindholm Olinder A
Pediatr Diabetes; 2015 Nov; 16(7):546-53. PubMed ID: 25327782
[TBL] [Abstract][Full Text] [Related]
24. The impact of continuous subcutaneous insulin infusion and multiple daily injections of insulin on glucose variability in older adults with type 2 diabetes.
Johnson SL; McEwen LN; Newton CA; Martin CL; Raskin P; Halter JB; Herman WH
J Diabetes Complications; 2011; 25(4):211-5. PubMed ID: 21062674
[TBL] [Abstract][Full Text] [Related]
25. Long-term body weight trajectories and metabolic control in type 1 diabetes patients on insulin pump or multiple daily injections: A 10-year retrospective controlled study.
Alderisio A; Bozzetto L; Franco L; Riccardi G; Rivellese AA; Annuzzi G
Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1110-1117. PubMed ID: 31371264
[TBL] [Abstract][Full Text] [Related]
26. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
Yeh HC; Brown TT; Maruthur N; Ranasinghe P; Berger Z; Suh YD; Wilson LM; Haberl EB; Brick J; Bass EB; Golden SH
Ann Intern Med; 2012 Sep; 157(5):336-47. PubMed ID: 22777524
[TBL] [Abstract][Full Text] [Related]
27. Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.
Hirsch IB; Bode BW; Garg S; Lane WS; Sussman A; Hu P; Santiago OM; Kolaczynski JW;
Diabetes Care; 2005 Mar; 28(3):533-8. PubMed ID: 15735183
[TBL] [Abstract][Full Text] [Related]
28. Switch to multiple daily injections with insulin glargine and insulin lispro from continuous subcutaneous insulin infusion with insulin lispro: a randomized, open-label study using a continuous glucose monitoring system.
Bode BW; Steed RD; Schleusener DS; Strange P
Endocr Pract; 2005; 11(3):157-64. PubMed ID: 16239201
[TBL] [Abstract][Full Text] [Related]
29. Continuous glucose monitoring in children with type 1 diabetes: before and after insulin pump therapy.
Heptulla RA; Allen HF; Gross TM; Reiter EO
Pediatr Diabetes; 2004 Mar; 5(1):10-5. PubMed ID: 15043684
[TBL] [Abstract][Full Text] [Related]
30. Treatment satisfaction and glycemic control in young Type 1 diabetic patients in transition from pediatric health care: CSII versus MDI.
Maiorino MI; Bellastella G; Petrizzo M; Improta MR; Brancario C; Castaldo F; Olita L; Giugliano D
Endocrine; 2014 Jun; 46(2):256-62. PubMed ID: 24078410
[TBL] [Abstract][Full Text] [Related]
31. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes.
Boland EA; Grey M; Oesterle A; Fredrickson L; Tamborlane WV
Diabetes Care; 1999 Nov; 22(11):1779-84. PubMed ID: 10546007
[TBL] [Abstract][Full Text] [Related]
32. A comparison of multiple daily insulin therapy with continuous subcutaneous insulin infusion therapy in adolescents with type 1 diabetes mellitus: a single-center experience from Turkey.
Abaci A; Atas A; Unuvar T; Demir K; Bober E; Büyükgebiz A
J Pediatr Endocrinol Metab; 2009 Jun; 22(6):539-45. PubMed ID: 19694201
[TBL] [Abstract][Full Text] [Related]
33. Continuous subcutaneous insulin infusion versus multiple daily injection therapy in pregnant women with type 1 diabetes.
Gong Y; Wei T; Liu Y; Wang J; Yan J; Yang D; Luo S; Weng J; Zheng X
J Diabetes; 2024 May; 16(5):e13558. PubMed ID: 38664886
[TBL] [Abstract][Full Text] [Related]
34. Real-time continuous glucose monitoring or continuous subcutaneous insulin infusion, what goes first?: results of a pilot study.
Moreno-Fernandez J; Gomez FJ; Gazquez M; Pedroche M; García-Manzanares A; Tenias JM; Benito P; Gomez IR
Diabetes Technol Ther; 2013 Jul; 15(7):596-600. PubMed ID: 23631604
[TBL] [Abstract][Full Text] [Related]
35. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes.
Herman WH; Ilag LL; Johnson SL; Martin CL; Sinding J; Al Harthi A; Plunkett CD; LaPorte FB; Burke R; Brown MB; Halter JB; Raskin P
Diabetes Care; 2005 Jul; 28(7):1568-73. PubMed ID: 15983302
[TBL] [Abstract][Full Text] [Related]
36. Long-term metabolic effects of continuous subcutaneous insulin infusion therapy in type 1 diabetes.
Cohen ND; Hong ES; Van Drie C; Balkau B; Shaw J
Diabetes Technol Ther; 2013 Jul; 15(7):544-9. PubMed ID: 23617252
[TBL] [Abstract][Full Text] [Related]
37. Long-Term Effectiveness of Continuous Subcutaneous Insulin Infusion in the Prevention of Hypoglycemia in Adults with Type 1 Diabetes.
Summers JC; Briganti EM; Fitzgerald ZA; Lambers LNJ; Cohen ND
Diabetes Technol Ther; 2019 Aug; 21(8):423-429. PubMed ID: 31180239
[No Abstract] [Full Text] [Related]
38. Fear of hypoglycemia in type 1 diabetes managed by continuous subcutaneous insulin infusion: is it associated with poor glycemic control?
Nixon R; Pickup JC
Diabetes Technol Ther; 2011 Feb; 13(2):93-8. PubMed ID: 21284474
[TBL] [Abstract][Full Text] [Related]
39. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C;
BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112
[TBL] [Abstract][Full Text] [Related]
40. Intensive insulin therapy combined with metformin is associated with reduction in both glucose variability and nocturnal hypoglycaemia in patients with type 2 diabetes.
Zhang Y; Zhao Z; Wang S; Zhu W; Jiang Y; Sun S; Chen C; Wang K; Mu L; Cao J; Zhou Y; Gu W; Hong J; Wang W; Ning G
Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28609547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
